Gene therapy approaches to regenerating bone von Kimelman Bleich, Nadav, Kallai, Ilan, Lieberman, Jay R., Schwarz, Edward M., Pelled, Gadi, Gazit, Dan

Volltext

Matrix stiffness determines the fate of nucleus pulposus–derived stem cells von Navaro, Yosi, Bleich-Kimelman, Nadav, Hazanov, Lena, Mironi-Harpaz, Iris, Shachaf, Yonatan, Garty, Shai, Smith, Yoav, Pelled, Gadi, Gazit, Dan, Seliktar, Dror, Gazit, Zulma

Volltext

Smad8/BMP2-engineered mesenchymal stem cells induce accelerated recovery of the biomechanical properties of the achilles tendon von Pelled, Gadi, Snedeker, Jess G., Ben-Arav, Ayelet, Rigozzi, Samuela, Zilberman, Yoram, Kimelman-Bleich, Nadav, Gazit, Zulma, Müller, Ralph, Gazit, Dan

Volltext

2052-LB: Semaglutide Depot, a Long-Acting Injection of Semaglutide Administered Once Every Four Weeks, Demonstrates Similar Efficacy and PK Profile to Daily Semaglutide Administrat... von Rubnov, Shai, Zats, Galina, Kimelman, Nadav Bleich, Popper, Laura, Danon, Uri, Marom, Ehud

Volltext

Oral Administration of a Novel Small Molecule Blocks the BMP Canonical and the Non-canonical BMP2, BMP4, and BMP5 Signaling Pathways Ameliorates EAE Through Oligodendrogenesis Remy... von Golan, Maya, Benhamou, Moshe, Fainberg, Karin, Kimelman, Nadav Bleich, Rubnov, Shai, Danon, Uri, Marom, Ehud, Karni, Arnon

Volltext

Specific Blockade of Bone Morphogenetic Protein-2/4 induces Oligodendrogenesis and Remyelination in Demyelinating Disorders (2042) von Fainberg-Mausner, Karin, Benhamou, Moshe, Golan, Maya, Kimelman, Nadav Bleich, Danon, Uri, Marom, Ehud, Karni, Arnon

Volltext

Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders von Mausner-Fainberg, Karin, Benhamou, Moshe, Golan, Maya, Kimelman, Nadav Bleich, Danon, Uri, Marom, Ehud, Karni, Arnon

Volltext

Glatiramer Acetate Depot (Extended-Release) Phase IIa Study in Patients with Primary Progressive Multiple Sclerosis: Safety and Efficacy Snapshot (P7-4.001) von Flechter, Shlomo, Popper, Laura, Kimelman, Nadav Bleich, Rubnov, Shai, Danon, Uri, Marom, Ehud, Milo, Ron, Gilad, Ronit, Weller, Boaz, Vaknin-Dembinsky, Adi, Hellman, Mark, Shifrin, Alla, Karni, Arnon

Volltext

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with Primary Progressive Multiple Sclerosis: safety and efficacy snapshot (1911) von Flechter, Shlomo, Popper, Laura, Demender, Inna, Kimelman, Nadav Bleich, Rubnov, Shai, Danon, Uri, Marom, Ehud, Milo, Ron, Gilad, Ronit, Weller, Boaz, Vaknin-Dembinsky, Adi, Hellmann, Mark, Karni, Arnon

Volltext

Five Years Analysis of anti-Glatiramer Acetate (GA) Antibodies in Patients with Relapsing Remitting Multiple Sclerosis Treated with GA Depot (P5-4.010) von Flechter, Shlomo, Miller, Ariel, Popper, Laura, Kimelman, Nadav Bleich, Rubnov, Shai, Danon, Uri, Marom, Ehud, Milo, Ron, Chapman, Joab, Shifrin, Alla, Gilad, Ronit, Hoffmann, Chen, Ben Hur, Tamir, Karussis, Dimitrios, Karni, Arnon

Volltext

Molecular targets for tendon neoformation von Aslan, Hadi, Kimelman-Bleich, Nadav, Pelled, Gadi, Gazit, Dan

Volltext

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with primary progressive multiple sclerosis: safety and efficacy snapshot (1956) von Flechter, Shlomo, Popper, Laura, Kimelman, Nadav Bleich, Demender, Inna, Rubnov, Shai, Danon, Uri, Marom, Ehud, Milo, Ron, Gilad, Ronit, Weller, Boaz, Vaknin-Dembinsky, Adi, Hellmann, Mark, Karni, Arnon

Volltext

Targeted Gene-and-host Progenitor Cell Therapy for Nonunion Bone Fracture Repair von Kimelman-Bleich, Nadav, Pelled, Gadi, Zilberman, Yoram, Kallai, Ilan, Mizrahi, Olga, Tawackoli, Wafa, Gazit, Zulma, Gazit, Dan

Volltext

Gene-Modified Adult Stem Cells Regenerate Vertebral Bone Defect in a Rat Model von Sheyn, Dmitriy, Kallai, Ilan, Tawackoli, Wafa, Cohn Yakubovich, Doron, Oh, Anthony, Su, Susan, Da, Xiaoyu, Lavi, Amir, Kimelman-Bleich, Nadav, Zilberman, Yoram, Li, Ning, Bae, Hyun, Gazit, Zulma, Pelled, Gadi, Gazit, Dan

Volltext

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with relapsing remitting multiple sclerosis: safety, tolerability and efficacy (No Evidence of Disease Activ... von Flechter, Shlomo, Miller, Ariel, Popper, Laura, Kimelman, Nadav Bleich, Rubnov, Shai, Danon, Uri, Marom, Ehud, Milo, Ron, Chapman, Joab, Shifrin, Alla, Gilad, Ronit, Hoffmann, Chen, Karussis, Dimitrios, Karni, Arnon

Volltext

Peptide-Modified “Smart” Hydrogels and Genetically Engineered Stem Cells for Skeletal Tissue Engineering von Garty, Shai, Kimelman-Bleich, Nadav, Hayouka, Zvi, Cohn, Daniel, Friedler, Assaf, Pelled, Gadi, Gazit, Dan

Volltext

Pre-Clinical Studies and Evaluation of Treatment Need of Glatiramer Acetate Depot (Long Acting Injection) (P5.314) von Bleich Kimelman, Nadav, Rubnov, Shai, Danon, Uri, Marom, Ehud, Miller, Ariel

Volltext

Glatiramer Acetate Depot (Extended-Release) Phase IIa Study in Patients with Relapsing Remitting Multiple Sclerosis: Safety, Tolerability and Efficacy (No Evidence of Disease Activ... von Flechter, Shlomo, Miller, Ariel, Popper, Laura, Kimelman, Nadav Bleich, Rubnov, Shai, Danon, Uri, Marom, Ehud, Milo, Ron, Chapman, Joab, Shifrin, Alla, Gilad, Ronit, Hoffmann, Chen, Karussis, Dimitrios, Karni, Arnon

Volltext

The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo von Kimelman-Bleich, Nadav, Pelled, Gadi, Sheyn, Dima, Kallai, Ilan, Zilberman, Yoram, Mizrahi, Olga, Tal, Yamit, Tawackoli, Wafa, Gazit, Zulma, Gazit, Dan

Volltext

Glatiramer Acetate Depot (extended-release) Phase IIa one-year study in patients with Relapsing-remitting Multiple Sclerosis: Safety, tolerability and efficacy – NEDA Analysis (P6.... von Miller, Ariel, Popper, Laura, Danon, Uri, Kimelman, Nadav Bleich, Rubnov, Shai, Marom, Ehud, Chapman, Joab, Shifrin, Alla, Gilad, Ronit, Karussis, Dimitrios, Milo, Ron, Hoffmann, Chen, Flechter, Shlomo, Karni, Arnon

Volltext